VICTORIA NARVAEZ VELEZ: Open Payments
NPI 1679277271 · AZLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,707 in 90 payments from 17 companies in 2025. Trend: 2023 $718 · 2024 $2,264 · 2025 $1,707
Food & beverage: $1,628Education: $79
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $455 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $265 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $256 |
| Madrigal Pharmaceuticals | 6 | $129 |
| Regeneron Healthcare Solutions, Inc. | 3 | $92 |
| QOL Medical, LLC | 3 | $87 |
| Janssen Biotech, Inc. | 1 | $79 |
| Phathom Pharmaceuticals, Inc. | 7 | $72 |
| PFIZER INC. | 4 | $70 |
| Lilly USA, LLC | 2 | $36 |
Products named: ENTYVIO, RINVOQ, SKYRIZI, XIFAXAN, REZDIFFRA, DUPIXENT, Sucraid, LINZESS.
Industry payments across TX — which companies pay providers there.
